The xerocytosis of Hb SC disease.
Patients with Hb SC disease were found to have microcytic and hyperchromic red cell indices despite mild reticulocytosis. Iron deficiency anemia was ruled out by the finding of normal serum ferritin levels. In order to determine whether the microcytosis was due to coexistent alpha-thalassemia, restriction endonuclease mapping was performed on genomic DNA extracted from peripheral blood leukocytes. Patients with Hb SC disease had microcytic indices despite the presence of a full complement of four alpha-genes (alpha alpha/alpha alpha), suggesting that the microcytosis may be due to cellular dehydration (or xerocytosis), since the mean corpuscular hemoglobin concentration in Hb SC disease patients was significantly higher than in controls. This possibility was investigated further by the determination of RBC cation content. RBC Na levels were similar in SC and normal red cells. Hb SC RBCs, however, had significantly reduced K levels. These findings show that RBC cation content, and thus cell water, is decreased in Hb SC disease. The decreased RBC K level in the presence of normal cellular Na concentration suggests selective K loss that is not due to inhibition of the Na K pump. Ouabain-insensitive K+ efflux was increased to four times normal in SC cells. Cell dehydration was confirmed by the demonstration of increased high-density RBCs on discontinuous Stractan density gradients and by osmotic gradient ektacytometry. Cellular dehydration and its sequelae were worse in CC erythrocytes and milder in AC cells than in Hb SC red cells. Taken together, these data indicate that in Hb SC disease the RBCs are severely dehydrated and typically microcytic and hyperchromic. Hb SC RBCs seem to be dehydrated due to selective K loss. These findings suggest a functional interrelationship between Hb SC, the red cell membrane, and cation regulation.
D000251:Adenosine Triphosphatases / Q000097:blood; D000755:Anemia, Sickle Cell / Q000097:blood*; D004907:Erythrocyte Deformability; D004910:Erythrocyte Membrane / Q000502:physiology; D004913:Erythrocytes, Abnormal / Q000032:analysis* / Q000473:pathology / Q000502:physiology; D005293:Ferritins / Q000097:blood; D005665:Furosemide / Q000494:pharmacology; D005914:Globins / Q000235:genetics; D006445:Hemoglobin C Disease / Q000097:blood; D006450:Hemoglobin SC Disease / Q000097:blood* / Q000235:genetics / Q000503:physiopathology; D006801:Humans; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D013449:Sulfonamides / Q000494:pharmacology; D014882:Water-Electrolyte Balance
D013449:Sulfonamides; D005665:Furosemide; D005914:Globins; D005293:Ferritins; D012964:Sodium; C015451:piretanide; D000251:Adenosine Triphosphatases; D011188:Potassium